MISSISSAUGA, Ontario,
Feb. 16, 2017 /PRNewswire/
-- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX:
ARZ), a global specialty pharmaceutical company, today
announced that executive management will participate in the RBC
Capital Markets Global Healthcare Conference to be held
February 22-23, 2017. Adrian Adams, Chief Executive Officer, will
provide an overview of the Company at 1:35
p.m. local time on Wednesday,
February 22, 2017.
A live webcast and audio archive for the event may be accessed
from the Investors section of the Aralez website at www.aralez.com.
Please connect to the website prior to the start of the
presentation to ensure adequate time for any software downloads
that may be necessary to listen to the
webcast.
About Aralez Pharmaceuticals Inc.
Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ and TSX: ARZ) is a
global specialty pharmaceutical company focused on delivering
meaningful products to improve patients' lives while creating
shareholder value by acquiring, developing and commercializing
products primarily in cardiovascular, pain and other specialty
areas. Aralez's Global Headquarters is in Mississauga, Ontario, Canada, its U.S.
Headquarters is in Princeton, NJ
and the Ireland Headquarters is in Dublin, Ireland. More information about Aralez
can be found at www.aralez.com.
Contact Information:
Aralez Pharmaceuticals US
Inc.
Nichol Ochsner
Executive Director,
Investor Relations & Corporate Communications
609.917.9303
nochsner@aralez.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/aralez-to-present-at-the-rbc-capital-markets-global-healthcare-conference-300408985.html
SOURCE Aralez Pharmaceuticals Inc.